Adult Attention-Deficit/Hyperactivity Disorder (ADHD). Attention-deficit hyperactivity disorders
Conditions
Interventions
Intervention 1: Intervention group: Unified Protocol for Transdiagnostic Treatment. The unified protocol for transdiagnostic treatment for emotional disorders consists of up to 12 sessions of 45 minu
identifying emotion-driven behaviors and replacing them with adaptive behaviors
recognizing and preventing emotional avoidance
increasing awareness of and exposure to bodily sensations
and modulating and confronting emotions in context. Intervention 2: Control group: The waitlist group will receive the unified protocol for transdiagnostic treatment. After the intervention group's fo
Sponsors
The University of Kurdistan
Eligibility
Sex/Gender
All
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Having diagnostic criteria for Adult ADHD and a comorbid emotional disorder Age range of 18 to 35 years Full consent to participate in the research Not receiving other therapeutic interventions concurrently with the present study
Exclusion criteria
Exclusion criteria: The presence of other psychological disorders and personality disorders except for the mentioned emotional disorders Absence from more than two therapy sessions Having a history of substance and psychotropic drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The ADHD score on the Adult ADHD Self-Report Scale (ASRS). Timepoint: Before treatment; after treatment; one months after the completion of treatment. Method of measurement: Adult ADHD Self-Report Scale (ASRS).;Depression score on the Beck Depression Inventory (BDI_II). Timepoint: Before treatment; after treatment; one months after the completion of treatment. Method of measurement: Beck Depression Inventory (BDI_II).;The anxiety score in the Beck Anxiety Inventory. Timepoint: Before treatment; after treatment; one months after the completion of treatment. Method of measurement: Beck Anxiety Inventory - BAI.;Frustration tolerance score on the Harrington Frustration Discomfort Scale. Timepoint: Before treatment; after treatment; one months after the completion of treatment. Method of measurement: Harrington Frustration Discomfort Scale.;Anxiety Sensitivity score in the Anxiety Sensitivity Index (ASI) questionnaire. Timepoint: Before treatment; after treatment; one months after the completion of treatment. Method of measurement: Anxiety Sensitivity score in the Anxiety Sensitivity Index (ASI) questionnaire.;Emotion Regulation score on the Emotion Regulation Questionnaire (ERQ) by Gross. Timepoint: Before treatment; after treatment; one months after the completion of treatment. Method of measurement: Emotion Regulation Questionnaire (ERQ) by Gross.;Response inhibition score on the Go/No-Go task. Timepoint: Before treatment; after treatment; one months after the completion of treatment. Method of measurement: Go/No-Go task.;Risky decision-making score in the Iowa Gambling Task. Timepoint: Before treatment; after treatment; one months after the completion of treatment. Method of measurement: Iowa Gambling Task.;Sustained attention score in the Continuous Performance Test (CPT). Timepoint: Before treatment; after treatment; one months after the completion of treatment. Method of measurement: Continuous Performance Test (CPT). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Khazaei Soltanabadi
The University of Kurdistan
Outcome results
None listed